drugset / Trial / NCT03810625

Food Effect Study of D-0502 Tablet in Healthy Volunteers

NCT03810625

Phase 1 Completed 14 enrolled InventisBio Co., Ltd
RandomizedCrossoverOpen-labelTreatment

Summary

This is an open label, randomized, balanced, single dose, two-treatment (fed vs. fasting), two-period, two-sequence crossover study of postmenopausal female healthy subjects.

Timeline

Start
2018-10-23
Primary completion
2018-11-21
Completion
2019-04-17

Drugs

EvaluationDrugModalityDoseRoute
Subject TARAGARESTRANT Small molecule Oral

Indications